comparemela.com

Latest Breaking News On - Richard anzalone - Page 1 : comparemela.com

Arrowhead Pharmaceuticals, Inc (NASDAQ:ARWR) Given Consensus Rating of Moderate Buy by Analysts

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Free Report) has been given an average recommendation of “Moderate Buy” by the thirteen analysts that are presently covering the firm, Marketbeat.com reports. Five investment analysts have rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average 12-month price target […]

E Fund Management Co Ltd Has $411,000 Holdings in Arrowhead Pharmaceuticals, Inc (NASDAQ:ARWR)

E Fund Management Co. Ltd. grew its stake in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) by 20.9% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 15,293 shares of the biotechnology company’s stock after purchasing an additional 2,647 shares during the […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.